Long-term effects of denosumab on bone mineral density and turnover markers in patients undergoing hemodialysis

被引：0
|
作者：
Kazuhiko Kato
Tatsuhiro Yaginuma
Arisa Kobayashi
Akio Nakashima
Ichiro Ohkido
Takashi Yokoo
机构：
[1] The Jikei University School of Medicine,Division of Nephrology and Hypertension, Department of Internal Medicine
[2] The Jikei University School of Medicine,Division of Molecular Epidemiology
[3] Keijin Hospital,Division of Nephrology
[4] Kyoto University Graduate School of Medicine,Human Health Sciences
来源：
Journal of Bone and Mineral Metabolism | 2024年 / 42卷
关键词：
Bone mineral density; Bone turnover markers; Denosumab; Hemodialysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：264 / 270
页数：6
相关论文
共 50 条
  • [41] Effects of lanthanum carbonate on bone markers and bone mineral density in incident hemodialysis patients
    Kimihiko Goto
    Shunsuke Goto
    Hideki Fujii
    Kentaro Watanabe
    Keiji Kono
    Shinichi Nishi
    [J]. Journal of Bone and Mineral Metabolism, 2019, 37 : 1075 - 1082
  • [42] Effects of cinacalcet on bone mineral density and bone markers in hemodialysis patients with secondary hyperparathyroidism
    Tsuruta, Yuki
    Okano, Kazuhiro
    Kikuchi, Kan
    Tsuruta, Yukio
    Akiba, Takashi
    Nitta, Kosaku
    [J]. CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2013, 17 (01) : 120 - 126
  • [43] Effects of cinacalcet on bone mineral density and bone markers in hemodialysis patients with secondary hyperparathyroidism
    Yuki Tsuruta
    Kazuhiro Okano
    Kan Kikuchi
    Yukio Tsuruta
    Takashi Akiba
    Kosaku Nitta
    [J]. Clinical and Experimental Nephrology, 2013, 17 : 120 - 126
  • [44] Effect of long-term oral anticoagulant therapy on bone mineral density and bone turnover markers: a prospective 12 month study
    Stenova, E.
    Steno, B.
    Killinger, Z.
    Baqi, L.
    Payer, J.
    [J]. BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2011, 112 (02): : 71 - 76
  • [45] Long-term effects of magnesium carbonate on coronary artery calcification and bone mineral density in hemodialysis patients: A pilot study
    Spiegel, David M.
    Farmer, Beverly
    [J]. HEMODIALYSIS INTERNATIONAL, 2009, 13 (04) : 453 - 459
  • [46] ASSESSMENT OF BONE MINERAL DENSITY AND BONE TURNOVER MARKERS IN POSTMENOPAUSAL WOMEN TRANSITIONED FROM ALENDRONATE TO DENOSUMAB
    Roux, C.
    Brown, J. P.
    Kendler, D. L.
    Lillestol, M.
    Siddhanti, S.
    Man, H. S.
    Martin, J. San
    Bone, H. G.
    Benhamou, C. L.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 10 - 11
  • [47] Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates
    Dore, Robin K.
    Cohen, Stanley B.
    Lane, Nancy E.
    Palmer, William
    Shergy, William
    Zhou, Lifen
    Wang, Huei
    Tsuji, Wayne
    Newmark, Richard
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (05) : 872 - 875
  • [48] Bone mineral density and bone turnover in asthmatics treated with long-term inhaled or oral glucocorticoids
    Ebeling, PR
    Erbas, B
    Hopper, JL
    Wark, JD
    Rubinfeld, AR
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1998, 13 (08) : 1283 - 1289
  • [49] Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients: response to comments
    M. Kamimura
    Y. Nakamura
    S. Ikegami
    S. Uchiyama
    H. Kato
    A. Taguchi
    [J]. Osteoporosis International, 2017, 28 : 1757 - 1758
  • [50] Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients: response to comments
    Kamimura, M.
    Nakamura, Y.
    Ikegami, S.
    Uchiyama, S.
    Kato, H.
    Taguchi, A.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2017, 28 (05) : 1757 - 1758
12345